OncLive - Bringing the Oncology Community Together

Olanzapine Proves Effective in Breakthrough CINV

Olanzapine, an antipsychotic medication that has been used off-label to treat patients experiencing chemotherapy-induced nausea and vomiting (CINV).

Conferences > 2012 ASCO Annual Meeting

Dr. Markman on PCP Awareness of Long-Term Side Effects

Dr. Maurie Markman, Cancer Treatment Centers of America, on Primary Care Physician Awareness of Long-Term Chemotherapy Side Effects

Conferences > 2012 ASCO Annual Meeting

PCPs Highly Unaware of Long-Term Chemotherapy Side Effects

Many primary care providers and some oncologists are unaware of the long-term effects of four chemotherapy drugs used to treat two of the most common forms of cancer.

Conferences > 2012 ASCO Annual Meeting

Dr. Kazmi Discusses Olanzapine for Breakthrough CINV

Dr. Shayma Kazmi, from Cancer Treatment Centers of America, on Olanzapine for Breakthrough Chemotherapy-Induced Nausea and Vomiting

Conferences > 2012 ASCO Annual Meeting

Long-Term Breast Cancer Patient Follow-Up Care: Money Well Spent?

J. Michael Dixon, MBChB, MD, and Patrick I. Borgen, MD, discuss the pros and cons of long-term clinical follow-up care of patients with breast cancer.

Oncology Live > Conference Highlights

Krista Rubin on Managing Ipilimumab-related Dermatitis

Krista Rubin, MS, RN, FNP-BC, from Massachusetts General Hospital Cancer Center, on Managing Ipilimumab-related Dermatitis.

Conferences > 2012 Oncology Nursing Society Congress

Oncology Nurses Can Help Mitigate Treatment-Related Side Effects in Head and Neck Cancers

Treatment of head and neck cancer often leaves patients with aftereffects that are bothersome at the very least and life-altering at their worst.

Conferences > 2012 Oncology Nursing Society Congress

Anne Katz Discusses Cancer and Sexuality

Anne Katz, from the University of Manitoba, Discusses Cancer and Sexuality

Conferences > 2012 Oncology Nursing Society Congress

Kim Kelly on Clinical Practice Guidelines for Mucositis

Kim Kelly, from John Theurer Cancer Center, on the Updated MASCC/ISOO Clinical Practice Guidelines for Mucositis

Conferences > 2012 Oncology Nursing Society Congress

Challenges and Breakthroughs in Cancer Pain Management

Cancer pain management has greatly improved with advances in oral and intravenous medication. However, several challenges still exist in administration.

OncLive Nursing > Conference Highlights

Urgent Need for Survivorship Planning

Thanks to earlier detection and improved treatment, the population of cancer survivors has increased dramatically and will continue to increase as the baby boomers age.

Oncology & Biotech News > Conference Highlights

Patients who undergo chemotherapy for breast cancer may develop fatigue that remains problematic long after they complete treatment.

Oncology & Biotech News > Clinical Trial Reports

What Patients Don't Know Might Hurt Them

Complementary! Sounds good, how could it hurt? When applied in cancer therapy, however, what sounds good may not always be good for patients.

Oncology & Biotech News > From the Editor

Premature Tamoxifen Withdrawal Is Common in Male Patients With Breast Cancer

New data show that roughly one-fifth of tamoxifen-treated male patients with breast cancer stop treatment early because of side effects.

Oncology & Biotech News > Clinical Trial Reports

Outpatient Treatment Approved for Low-Risk Febrile Neutropenia

Outpatient management in patients with cancer who have a low risk of severe febrile neutropenia is an effective and safe option to standard inpatient treatment.

Oncology & Biotech News > Clinical Trial Reports

Oncofertility, Osteonecrosis Emerge as Patient Concerns

Supportive care is a crucial component of personalized oncology care.

Oncology Live > Specialty Focus

Peripheral Neuropathy Profile More Favorable With Eribulin

Patients with metastatic breast cancer who were treated with eribulin mesylate were less likely to experience peripheral neuropathy.

Oncology Live > Conference Highlights

Transplant Recipients Have Higher Risk of Diverse Cancers

Patients who receive a solid organ transplant have about twice the risk of developing cancer as the general population.

Oncology & Biotech News > Clinical Trial Reports

Mouth Care Systems Alleviate Xerostomia After Radiotherapy

Radiotherapy often results in the loss of some salivary gland function, causing hyposalivation and xerostomia.

Oncology & Biotech News > News

Psychosocial Considerations in Cancer Care

Cancer treatment addresses a patient's physical health but the mental state of the patient is something that might need more than an oncologist's expertise.

OncLive Nursing > Conference Highlights